TABLE 4.
Laboratory strains and clinical isolates used in this work
| Strain | blaOXA genea | Strain description | Reference or source |
|---|---|---|---|
| E. coli BL21 | NA | F− ompT hsdSB(rB− mB−) gal dcm | ATCC |
| E. coli TG1 | NA | supE hsdΔ5 thi Δ(lac-proAB) F′ [traD36 proAB+ lacIqΔM15] | ATCC |
| A. baumannii Ab1 | OXA-23 | A. baumannii clinical isolate, isolated from bronchial aspirate from Spain | 60 |
| A. baumannii RYC 52763/97 | OXA-24/40 | A. baumannii clinical isolate, isolated from bronchial aspirate from Spain, first description of OXA-24/40 | 12 |
| A. baumannii ATCC17978 | OXA-95 (OXA-51-like) | A. baumannii type strain, OXA-51 like variant OXA-95, completely sequenced reference strain | ATCC |
| A. baumannii HRS1 | OXA-58 | A. baumannii clinical isolate from Spain | 59 |
| A. baumannii 135040 | OXA-143 | A. baumannii clinical isolate, isolated from blood culture from Brazil, first description of OXA-143 | 15 |
| A. baumannii AF 401 | OXA-235 | A. baumannii clinical isolate, isolated from small intestine from Mexico, first description of OXA-235 | 16 |
a
NA, not available.